Typhoid conjugate vaccine gets WHO prequalification.
作者信息
Burki Talha
出版信息
Lancet Infect Dis. 2018 Mar;18(3):258. doi: 10.1016/S1473-3099(18)30087-2.
Abstract
摘要
相似文献
1
Typhoid conjugate vaccine gets WHO prequalification.伤寒结合疫苗获得世界卫生组织预认证。
Lancet Infect Dis. 2018 Mar;18(3):258. doi: 10.1016/S1473-3099(18)30087-2.
2
Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012.2012 年 9 月 5 日至 7 日，在韩国济州岛举行了伤寒 Vi 荚膜多糖结合疫苗质量、安全性和效力工作组会议。
Vaccine. 2013 Sep 23;31(41):4466-9. doi: 10.1016/j.vaccine.2013.07.070. Epub 2013 Aug 6.
3
Introduction of Typhoid Conjugate Vaccines in Africa and Asia.非洲和亚洲的伤寒结合疫苗介绍。
Clin Infect Dis. 2019 Feb 15;68(Suppl 1):S27-S30. doi: 10.1093/cid/ciy878.
4
Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?加速伤寒结合疫苗引入：从先前新疫苗引入举措中学到了什么？
Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S171-S176. doi: 10.1093/cid/ciy1118.
5
Early Insights From Clinical Trials of Typhoid Conjugate Vaccine.伤寒疫苗临床试验的早期结果。
Clin Infect Dis. 2020 Jul 29;71(Suppl 2):S155-S159. doi: 10.1093/cid/ciaa370.
6
Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?用于预防儿童伤寒热的Vi多糖-蛋白质结合疫苗：希望还是炒作？
Expert Rev Vaccines. 2007 Jun;6(3):293-5. doi: 10.1586/14760584.6.3.293.
7
Madagascar should introduce typhoid conjugate vaccines now.马达加斯加现在应该引入伤寒结合疫苗。
Lancet. 2018 Oct 13;392(10155):1309-1310. doi: 10.1016/S0140-6736(18)31882-8.
8
Revised Global Typhoid Vaccination Policy.修订版全球伤寒疫苗接种政策。
Clin Infect Dis. 2019 Feb 15;68(Suppl 1):S31-S33. doi: 10.1093/cid/ciy927.
9
A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions.预测伤寒结合疫苗在伤寒地方性中低收入国家的引入和需求，以支持疫苗引入政策和决策。
Hum Vaccin Immunother. 2017 Sep 2;13(9):2017-2024. doi: 10.1080/21645515.2017.1333681. Epub 2017 Jun 12.
10
Gateway to Typhoid Conjugate Vaccine Introduction in India and Beyond-Programmatic Effectiveness of a Public Sector Typhoid Conjugate Vaccine Campaign in Navi Mumbai.印度及其他地区引入伤寒结合疫苗的门户——孟买新市镇公共部门伤寒结合疫苗接种运动的项目成效
Clin Infect Dis. 2023 Jul 5;77(1):145-147. doi: 10.1093/cid/ciad134.
引用本文的文献
1
Prolonged Fever in a Multidrug-Resistant Typhoid Fever Patient Despite Appropriate Antimicrobial Therapy: A Case Report.尽管采用了适当的抗菌治疗，耐多药伤寒热患者仍持续发热：一例报告
Cureus. 2025 Feb 14;17(2):e78999. doi: 10.7759/cureus.78999. eCollection 2025 Feb.
2
The Paratyphi A O-Antigen Glycoconjugate Vaccine Is Able to Induce Antibodies with Bactericidal Activity Against a Panel of Clinical Isolates.甲型副伤寒O抗原糖共轭疫苗能够诱导产生针对一组临床分离株具有杀菌活性的抗体。
Vaccines (Basel). 2025 Jan 25;13(2):122. doi: 10.3390/vaccines13020122.
3
Qualification of an enzyme-linked immunosorbent assay for quantification of anti-Vi IgG in human sera.酶联免疫吸附试验定量检测人血清中抗-Vi IgG 的方法学确证。
Front Immunol. 2024 Oct 16;15:1466869. doi: 10.3389/fimmu.2024.1466869. eCollection 2024.
4
Fighting the enemy within: Systemic immune defense against mucosal Salmonella infection.对抗体内敌人：针对黏膜沙门氏菌感染的全身免疫防御
Immunol Lett. 2024 Dec;270:106930. doi: 10.1016/j.imlet.2024.106930. Epub 2024 Sep 27.
5
Typhoid conjugate vaccine perceptions and coverage among children and adults: Findings from a post-campaign coverage survey - Harare, Zimbabwe, 2019.伤寒结合疫苗在儿童和成人中的认知和接种情况：来自 2019 年津巴布韦哈拉雷疫苗接种运动后覆盖情况调查的结果。
Vaccine. 2024 Oct 24;42(24):126086. doi: 10.1016/j.vaccine.2024.06.053. Epub 2024 Jul 10.
6
Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below 2 years: a systematic review and meta-analysis.2岁以下儿童Vi-白喉类毒素伤寒结合疫苗的安全性和免疫原性：一项系统评价和荟萃分析。
Front Microbiol. 2024 Apr 5;15:1385834. doi: 10.3389/fmicb.2024.1385834. eCollection 2024.
7
Trends in antimicrobial resistance amongst Salmonella Paratyphi A isolates in Bangladesh: 1999-2021.孟加拉国甲型副伤寒沙门氏菌分离株的抗生素耐药趋势：1999-2021 年。
PLoS Negl Trop Dis. 2023 Nov 8;17(11):e0011723. doi: 10.1371/journal.pntd.0011723. eCollection 2023 Nov.
8
Combination Vaccines: Moving Beyond Typhoid.联合疫苗：超越伤寒疫苗
Open Forum Infect Dis. 2023 Jun 2;10(Suppl 1):S58-S66. doi: 10.1093/ofid/ofad041. eCollection 2023 May.
9
Typhoid Control in an Era of Antimicrobial Resistance: Challenges and Opportunities.抗菌药物耐药时代的伤寒控制：挑战与机遇
Open Forum Infect Dis. 2023 Jun 2;10(Suppl 1):S47-S52. doi: 10.1093/ofid/ofad135. eCollection 2023 May.
10
Shigella-Controlled Human Infection Models: Current and Future Perspectives.志贺氏菌感染人体模型：现状和未来展望
Curr Top Microbiol Immunol. 2024;445:257-313. doi: 10.1007/82_2021_248.
Zotero 插件